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Direct thrombolytic therapy in portal and
mesenteric vein thrombosis
Charlie Chen, MD, New Haven, Conn
A 34-year-old female from Laos presented to the emergency department with a 3-week history of worsening abdominal
pain; she subsequently developed an acute abdomen requiring emergent exploratory laparotomy. An intraoperative
angiography was performed, which revealed complete portal vein thrombosis. A 5F 20-cm infusion catheter was placed
through an omental vein, and tissue plasminogen activator was administered directly into the catheter with successful
decrease in thrombus burden. There are few controlled data on which to base clinical decisions in patients with portal vein
thrombosis. Our case expands on these earlier reports that direct thrombolysis can be safely performed using local,
intraclot infusions for portal vein thrombosis, and thrombolytic doses can be kept relatively low, limiting the risk of
bleeding complications. ( J Vasc Surg 2012;56:1124-6.)
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A 34-year-old female from Laos presented to the emergency
department with a 3-week history of worsening abdominal pain,
which had significantly exacerbated over the last 48 hours. Pain was
characterized as diffuse and constant with radiation to the lower
back. She also endorsed nausea, nonbilious vomiting, anorexia,
sweats, and chills. The patient had several similar episodes recently
but of less intensity that resolved spontaneously. She also denied
any medical problems or prior surgeries. Her only medication was
oral contraceptives, which were started 1 month ago. She had no
known drug allergies and denied any alcohol, tobacco, or illicit drug
use.Thepatient immigrated into the country fromLaos6months ago
and had no immediate family in the region. Family history was
significant for gastric cancer but otherwise unremarkable.
On physical examination, her temperature was 97.6°F. Her
pulse had a regular rhythm with a rate of 80 beats per minute and
no murmurs, rubs, or gallops, and her blood pressure was 102/66
mm Hg. She appeared well-nourished but diaphoretic and in
distress secondary to abdominal discomfort. The abdomen was
tender to light palpation in all quadrants and distended, and she
had rebound tenderness and involuntary guarding. The rectal
examination revealed normal tone and guaiac-positive stool. She
did not have any obvious hernias or masses on examination.
The laboratory analysis revealed a normal white blood count at
9.2, hemoglobin 12.4, hematocrit 36.7, and lactic acid of 1.2. Her
liver function tests, chemistry panel, and coagulation profile were
all within normal limits. A computed tomography (CT) scan of the
abdomen and pelvis with intravenous and oral contrast was ob-
tained in the emergency department (Fig 1).
CT imaging revealed extensive portal vein thrombus involving
the main, right, and left portal veins extending into the superior
mesenteric vein and splenic vein. There was also noted diffuse
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1124hickening of the jejunal loops with hyperdense walls. Clinically,
he patient developed an acute abdomen.
Three hours after presentation to the emergency room, the
atient was emergently taken to the operating room for explor-
tory laparotomy because of subsequent development of acute
bdomen. Upon entering the intra-abdominal cavity, abundant
scites was encountered. Whereas mesenteric arteries remained
ulsatile on palpation, extensive thrombosis and engorgement
ere noted grossly in the mesenteric veins. The liver and spleen
ere unremarkable upon careful inspection. A 75-cm section of
he small bowel was found to be necrotic and resected. Whereas
urgical thrombectomy and angioplasty with stenting were consid-
red prior to the operation, the extent of the disease into mesen-
eric veins prompted us to favor local thrombolytic therapy. An
ngiography was, therefore, performed intraoperatively, which
evealed complete portal vein and superior mesenteric vein throm-
osis (Fig 2). This was done through a small incision made in an
mental vein, and a 5F 20-cm infusion catheter was inserted with
dvancement of the distal tip to the distal superior mesenteric vein
nder fluoroscopic guidance. The cannulized catheter was then
ecured in the omental vein using a 3-0 silk suture and externalized
hrough the patient’s left lower abdomen. Tissue plasminogen
ctivator (tPA; alteplase) was administered locally through the
atheter, and tPA infusion was started at 0.5 mg per hour postop-
ratively. The patient’s abdomen was left open with a temporary
bdominal closure device. Follow-up venogram the next day
evealed a decrease in thrombus burden in the portal vein,
uperior mesenteric vein, and splenic vein (Fig 3); the catheter
as, thus, retrieved and omental vein ligated, and her abdomen
as closed at that time. Heparinization was started postopera-
ively. The patient had a subsequent uneventful recovery with
omplete resolution of symptoms and was discharged on oral
nticoagulation. Ultimately, hypercoagulable workup started
reoperatively, which included factor V Leiden, prothrombin
0, 210 mutation, protein S deficiency, and antithrombin III
eficiency, revealed protein C deficiency in the patient. Al-
hough we considered schistosomiasis and other unusual forms
f abdominal and liver disease, given the patient’s recent immi-
ration from Laos, she did not have hepatosplenomegaly or
ther skin findings to suggest otherwise.
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Acute portal vein thrombosis is characterized by the
development of thrombus in the portal vein or its left or
right branches. Further extension to the mesenteric venous
Fig 1. Computed tomography (CT) abdomen and pelvis. Black
arrow points to extensive portal vein thrombus.
Fig 2. Intraoperative angiography. Black arrow points to site of
complete portal vein thrombosis.arches causes intestinal infarction, with a reported mortality tf up to 50%.1 Without recanalization, a cavernous heman-
ioma develops. These dilated, thin-walled collection of
essels are prone to potentially fatal gastrointestinal bleed-
ng, and stagnant blood within the channels is associated
ith thrombosis.2 Revascularization is, therefore, a major
oal for the treatment of portal vein thrombosis, which can
e a pressing challenge, as most cases are recognized in an
cute setting.
Various etiologies have been described for portal vein
hrombosis. In adults, approximately 25% of patients with
ortal vein thrombosis have underlying cirrhosis. In one
eries, portal vein thrombosis was identified in 79 of 701
ospitalized patients with cirrhosis (11%) who underwent
outine ultrasound screening.3 Of these, 34 (43%) were
symptomatic, whereas 45 (57%) had associated symptoms,
ncluding portal hypertensive bleeding, abdominal pain,
nd intestinal infarction secondary to concomitant mesen-
eric vein involvement. The annual incidence of portal vein
hrombosis among patients with cirrhosis is 1%. The
evelopment of portal vein thrombosis in patients with
irrhosis appears to correlate with the severity of underlying
iver disease.4 The factors behindwhy cirrhosis increases the
isk of portal vein thrombosis has not been well studied, but
t is presumed to be related to stasis or retrograde flow
hrough the portal vein.
In patients without cirrhosis, a plethora of causes for
ortal vein thrombosis have also been described. In one
eries of 184 such adults, 34% reported a prior history of
bdominal surgery, 14% had pancreaticobiliary disease, and
% had alimentary tract disease.5 These conditions may
ave predisposed patients to portal vein thrombosis be-
ause of direct injury to the portal vein, stasis of portal vein
lood flow, or general hypercoagulability. In another se-
ies, a local risk factor (eg, acute pancreatitis) was observed
n 21% of patients; in 52%, a prothrombotic mutation was
ound, including protein C deficiency, factor V Leiden,
ethylenetetrahydrofolate reductase gene mutation, and
rothrombin gene mutation.6 Other risk factors attributed
ig 3. Follow-up venogram post-tissue plasminogen activator
tPA) infusion. Black arrow points to the decrease in thrombus
urden with flow in portal, superior mesenteric, and splenic veins.o portal vein thrombosis include oral contraceptive use
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October 20121126 Chenand trauma. In children, themost common cause is ompha-
litis, which causes thrombophlebitis of the umbilical vein
and subsequently the portal vein. No apparent cause for
portal vein thrombosis is evident in more than 25% of
patients.6
Acute portal vein thrombosis is usually clinically silent
and often diagnosed during radiologic examination for
other reasons (such as acute pancreatitis). When symptom-
atic, portal vein thrombosis manifests in a variety of ways,
including hepatic dysfunction, ascites, splenomegaly, and
variceal bleeding. Patients in whom portal vein thrombosis
is suspected should undergo radiologic testing to define the
extent of the clot. Ultrasound with Doppler flow studies,
CT scanning, and magnetic resonance angiography are
often helpful in this setting. Venous phase angiography
remains the gold standard in patients in whom the diagno-
sis is strongly suspected. Most patients with portal vein
thrombosis should undergo evaluation for a hypercoagula-
ble state.
There are few controlled data on which to base clinical
decisions in patients with portal andmesenteric vein throm-
bosis. Therefore, treatment should be determined by the
individual patient’s clinical situation, the pathophysiology
involved, and the available expertise. Initial anticoagulation
should be started if the patient is stable without signs and
symptoms of surgical abdomen. Once an acute abdomen
develops, exploratory laparotomy is indicated and treat-
ment options include a portosystemic shunt, surgical
thrombectomy, angioplasty, or thrombolysis. Thromboses
of both portal and mesenteric veins are typically associated
with more congestion and fewer collateral vessels, as with
our case. We, therefore, suggest that thrombolytic therapy
can be favored in these circumstances administered locally
by a venous catheter. Alternate means of thrombolysis
through transjugular and transhepatic routes have been
described in the literature. However, retrograde access
through omental veins allows easy and safe access if the
patient has already undergone laparotomy for acute abdo-
men. Thrombolysis also has the advantage of lysing smaller
thrombi not targeted by mechanical thrombectomy. The
choice of thrombolysis agent should be considered: tPA
was favored in our patient over urokinase given compara-
tively less bleeding risk with tPA, especially in light of the
patient’s heme-positive stool. A 2009 guideline issued by
the American Association for the Study of Liver Diseases
recommends giving anticoagulation therapy for at least 3
months starting with low-molecular-weight heparin and Shifting to oral anticoagulation once the patient’s condition
as stabilized.7 In a study of patients with portal vein
hrombosis in which 27 patients were anticoagulated, anti-
oagulation was associated with recanalization of the portal
ein in about 40% of patients compared with none of the 11
atients who were not anticoagulated.8 Anticoagulation
hould be continued long term in patients with acute portal
ein thrombosis who have a permanent thrombotic risk
actor that is not correctable.
Our case expands on these earlier reports by illustrating
wo important points. First, thrombolysis can be safely
erformed using local, intraclot infusions for extensive
ortal vein and mesenteric vein thrombosis. Second,
hrombolytic doses can be kept relatively low, limiting the
isk of bleeding complications. Whereas low-dose throm-
olytic infusion is generally considered safe, treatment of
ortal vein is not commonly performed and can now be
onsidered when given in low doses. We believe this case
ighlights the effectiveness of direct intraclot infusion in
ecreasing thrombus burden and potentially limiting fur-
her bowel ischemia.
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